We are live on ! Find out more
ELAN icon

Elanco Animal Health

375 hedge funds and large institutions have $7.83B invested in Elanco Animal Health in 2024 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 103 increasing their positions, 142 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more call options, than puts

Call options by funds: $72.5M | Put options by funds: $21.1M

53% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 43

8% more capital invested

Capital invested by funds: $7.25B → $7.83B (+$584M)

6% more funds holding

Funds holding: 354375 (+21)

0.98% less ownership

Funds ownership: 98.68%97.69% (-0.98%)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

27% less repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 142

Holders
375
Holders Change
+21
Holders Change %
+5.93%
% of All Funds
5.4%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
66
Increased
103
Reduced
142
Closed
43
Calls
$72.5M
Puts
$21.1M
Net Calls
+$51.4M
Net Calls Change
+$5.58M
Name Holding Trade Value Shares
Change
Change in
Stake
DWM
376
Dogwood Wealth Management
Kansas
$1
WHCM
377
Wolf Hill Capital Management
Connecticut
-$20.7M -1,388,100 Closed
WP
378
Woodline Partners
California
-$18.3M -1,227,165 Closed
WMSA
379
Weiss Multi-Strategy Advisers
New York
-$7.54M -505,815 Closed
Connor, Clark & Lunn Investment Management (CC&L)
380
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$5.79M -388,459 Closed
Renaissance Technologies
381
Renaissance Technologies
New York
-$4.49M -301,244 Closed
Bank of Nova Scotia
382
Bank of Nova Scotia
Ontario, Canada
-$4M -268,760 Closed
LIP
383
Lighthouse Investment Partners
Florida
-$3.14M -210,476 Closed
TI
384
Trexquant Investment
Connecticut
-$2.93M -196,567 Closed
ECM
385
ExodusPoint Capital Management
New York
-$2.46M -165,105 Closed
ZIM
386
Zacks Investment Management
Illinois
-$2.28M -152,947 Closed
BAMF
387
BI Asset Management Fondsmaeglerselskab
Denmark
-$1.99M -133,653 Closed
FAM
388
Fred Alger Management
New York
-$1.92M -129,077 Closed
HighTower Advisors
389
HighTower Advisors
Illinois
-$1.5M -100,925 Closed
PI
390
PineBridge Investments
New York
-$1.09M -73,278 Closed
PE
391
Point72 Europe
United Kingdom
-$804K -53,988 Closed
OAC
392
OMERS Administration Corp
Ontario, Canada
-$767K -51,500 Closed
FRM
393
Fox Run Management
Connecticut
-$491K -32,938 Closed
VF
394
Virtu Financial
New York
-$368K -24,718 Closed
PCMH
395
Polymer Capital Management (HK)
Hong Kong
-$298K -20,000 Closed
XT
396
XTX Topco
Cayman Islands
-$294K -19,715 Closed
Acadian Asset Management
397
Acadian Asset Management
Massachusetts
-$237K -16,071 Closed
IC
398
Innealta Capital
Texas
-$209K -14,011 Closed
MPI
399
Mairs & Power Inc
Minnesota
-$200K -13,442 Closed
CC
400
Cipher Capital
New York
-$198K -13,300 Closed

ELAN Hedge Fund Activity: Q1 2024 in Review

375 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q1 2024, worth a combined $7.83B — up 8.1% from $7.25B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new ELAN positions and 43 closed out — a net gain of 23 holders — while 103 added to existing stakes and 142 trimmed.

The largest buyer was Marshall Wace, adding an estimated $82.9M. The largest seller was Morgan Stanley, cutting an estimated $115M.

  • 375 institutional investors held Elanco Animal Health (ELAN) as of Q1 2024, up from 354 in Q4 2023.
  • Funds reported $7.83B of Elanco Animal Health stock for Q1 2024, up 8.1% quarter-over-quarter.
  • 66 funds opened new Elanco Animal Health positions in Q1 2024 and 43 closed out, a net change of +23 holders.
  • The largest Elanco Animal Health buyer in Q1 2024 was Marshall Wace, an estimated $82.9M added.
  • The largest Elanco Animal Health seller in Q1 2024 was Morgan Stanley, an estimated $115M sold.

Based on aggregated 13F filings for Q1 2024.